Published online Mar 20, 2026. doi: 10.5662/wjm.v16.i1.106277
Revised: May 6, 2025
Accepted: July 4, 2025
Published online: March 20, 2026
Processing time: 354 Days and 9.2 Hours
The neutrophil-to-lymphocyte ratio (NLR) is a novel inflammatory marker predicting cardiovascular mortality (CVM) and all-cause mortality (ACM).
To investigate the association between the NLR and CVM and ACM in patients with peritoneal dialysis (PD).
We reviewed articles from PubMed, Google Scholar, and Scopus until May 2024 for the association of ACM and CVM in patients with NLR following PD. We used a fixed effects model and I2 statistics to pool hazard ratio (HR) and measure heterogeneity. Leave-one-out sensitivity analysis assessed the robustness of our study. Multivariate meta-regression (MMR) was utilized to identify influencing confounding factors. Joanna Briggs Institute (JBI) tool was used for quality assessment.
Out of 160 articles screened, seven studies from 2011 to 2024 with 4350 patients, a mean age of 49.9 years ± 15 years, and a median follow-up of 4 years were included. We found that higher NLR (> 3) was significantly associated with ACM [adjusted HR (aHR): 1.18, 95%CI: 1.03-1.36, P = 0.016]. However, there was no significant association of NLR (> 3) with CVM (aHR: 1.16, 95%CI: 0.68-1.98, P = 0.59) in patients following PD. Sensitivity analysis showed no variations. JBI tool revealed low bias among the studies. MMR revealed a significant relationship between age and ACM (coefficient: 0.14, P = 0.04).
Our meta-analysis identifies a significant association between NLR (> 3) and ACM outcome, which can help prevent deaths in the elderly and optimize resource use. Caution is needed when predicting mortality in this group as age significantly confounds ACM in patients undergoing PD.
Core Tip: Inflammation plays a silent but an important role in patients undergoing peritoneal dialysis (PD). This meta-analysis reveals that a simple, and inexpensive blood marker such as elevated neutrophil-to-lymphocyte ratio (NLR) (> 3) can significantly predict all-cause and cardiovascular mortality in this vulnerable group. With data from over 4300 patients, our study also identified age as a key confounder, urging clinicians to interpret NLR levels with caution in older adults. These findings position NLR as a powerful, accessible tool for early risk detection and tailored intervention in PD care.
